In today’s briefing:
- Caplin Point Labs: Forensic Analysis
Caplin Point Labs: Forensic Analysis
- Caplin Point Laboratories (CLPL IN) develops, produces, markets, and exports generic pharmaceutical formulations and branded products, including liquid and lyophilized injections, ophthalmic products, tablets, liquid orals, capsules, softgel capsules etc.
- While Caplin has a healthy 5 year CAGR growth ~28% and strong margins, it however has slowed down recently. The return ratios, turnover and cash conversion have been heading southwards.
- There have been some dubious accounting related to cash flows and asset quality, and few red-flags relating to few of the subsidiaries as well which should not be overlooked.
Before it’s here, it’s on Smartkarma
